Mary Guilfoyle

850 total citations
11 papers, 592 citations indexed

About

Mary Guilfoyle is a scholar working on Hematology, Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mary Guilfoyle has authored 11 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Biochemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mary Guilfoyle's work include Erythropoietin and Anemia Treatment (6 papers), Blood transfusion and management (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). Mary Guilfoyle is often cited by papers focused on Erythropoietin and Anemia Treatment (6 papers), Blood transfusion and management (5 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). Mary Guilfoyle collaborates with scholars based in United States, Australia and Netherlands. Mary Guilfoyle's co-authors include Mary C. Wacholtz, D. Frei, Wing K. Cheung, Betty L. Goon, Diane Young, Gene Landon, Hugh P. Chandler, Christopher P. Stowell, Maurice Jové and David Young and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Mary Guilfoyle

10 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Guilfoyle United States 10 347 342 117 87 86 11 592
Rachel S. Bercovitz United States 13 300 0.9× 317 0.9× 157 1.3× 82 0.9× 29 0.3× 35 671
J. P. Wallis United Kingdom 15 212 0.6× 402 1.2× 202 1.7× 118 1.4× 39 0.5× 31 753
Francesca Marangoni Italy 9 387 1.1× 295 0.9× 62 0.5× 41 0.5× 49 0.6× 18 577
Inga Hegemann Switzerland 13 241 0.7× 180 0.5× 66 0.6× 65 0.7× 47 0.5× 26 510
Ole H. Larsen Denmark 13 175 0.5× 74 0.2× 138 1.2× 86 1.0× 53 0.6× 32 466
Jonathan P. Wallis United Kingdom 16 132 0.4× 366 1.1× 201 1.7× 97 1.1× 90 1.0× 33 729
P Beris Switzerland 13 589 1.7× 368 1.1× 139 1.2× 155 1.8× 33 0.4× 27 959
J. M. Heal United States 9 314 0.9× 268 0.8× 36 0.3× 72 0.8× 57 0.7× 11 518
Thomas Geer Germany 7 185 0.5× 123 0.4× 29 0.2× 116 1.3× 135 1.6× 20 493
Paula F. Ypma Netherlands 15 464 1.3× 54 0.2× 34 0.3× 63 0.7× 100 1.2× 57 770

Countries citing papers authored by Mary Guilfoyle

Since Specialization
Citations

This map shows the geographic impact of Mary Guilfoyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Guilfoyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Guilfoyle more than expected).

Fields of papers citing papers by Mary Guilfoyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Guilfoyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Guilfoyle. The network helps show where Mary Guilfoyle may publish in the future.

Co-authorship network of co-authors of Mary Guilfoyle

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Guilfoyle. A scholar is included among the top collaborators of Mary Guilfoyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Guilfoyle. Mary Guilfoyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kumar, Vidya P., Gregory P. Holmes‐Hampton, Neel Sharma, et al.. (2022). Mitigation of total body irradiation-induced mortality and hematopoietic injury of mice by a thrombopoietin mimetic (JNJ-26366821). Scientific Reports. 12(1). 3485–3485. 20 indexed citations
2.
Pierson, Sheila K., Laura M. Katz, Jason R. Ruth, et al.. (2019). Quantitative Changes in Serum Proteins Including CXCL13 Are Early Indicators of Response to Anti-IL6 Therapy in Idiopathic Multicentric Castleman Disease. Blood. 134(Supplement_1). 3599–3599.
3.
Brighton, Timothy, Amit Khot, Simon J. Harrison, et al.. (2019). Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma. Clinical Cancer Research. 25(13). 3772–3775. 55 indexed citations
4.
Pierson, Sheila K., Dustin Shilling, Mary Guilfoyle, et al.. (2018). Predictors of response to anti‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data. British Journal of Haematology. 184(2). 232–241. 36 indexed citations
5.
Chakraborty, Abhijit, Jaya Natarajan, Mary Guilfoyle, et al.. (2005). Population Pharmacokinetics of Erythropoietin in Critically Ill Subjects. The Journal of Clinical Pharmacology. 45(2). 193–202. 9 indexed citations
7.
Stowell, Christopher P., Hugh P. Chandler, Maurice Jové, Mary Guilfoyle, & Mary C. Wacholtz. (1999). An Open-Label, Randomized Study to Compare the Safety and Efficacy of Perioperative Epoetin alfa With Preoperative Autologous Blood Donation in Total Joint Arthroplasty. Orthopedics. 22(1). s105–12. 76 indexed citations
8.
Cheung, Wing K., Betty L. Goon, Mary Guilfoyle, & Mary C. Wacholtz. (1998). Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects*. Clinical Pharmacology & Therapeutics. 64(4). 412–423. 86 indexed citations
9.
DʼAmbra, Michael N., Richard J. Gray, Robert S. Hillman, et al.. (1997). Effect of Recombinant Human Erythropoietin on Transfusion Risk in Coronary Bypass Patients. The Annals of Thoracic Surgery. 64(6). 1686–1693. 51 indexed citations
10.
Goldberg, Mark A., JOHN W. MCCUTCHEN, Richard J. Friedman, et al.. (1996). A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.. PubMed. 25(8). 544–52. 111 indexed citations
11.
Landon, Gene, et al.. (1996). Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.. PubMed. 25(8). 533–42. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026